Navigation Links
Antisense therapeutics scientist out to pull more big deals
Date:3/27/2008

Aiming for more major licensing deals like the one his company recently secured with top 20 global pharmaceutical company, Teva, is front of mind for rising Australian biotechnology star, Antisense Therapeutics Ltd (ASX code: ANP)Research Director Dr Christopher Wraight when he meets with leading industry figures in the US in May.

One of two Australian life scientists chosen from a highly competitive field of candidates for the prestigious 2008 Advancing BioBusiness Award, Dr Wraight will attend the worlds largest biotechnology meeting, the Biotechnology Industry Organisation (BIO) convention, which attracts over 22,000 delegates from around the globe.

A tailored program of meetings will also be scheduled for him with leading American players including venture capital firms, research institutes, biotechnology entrepreneurs and biopharmaceutical companies, to help build valuable international networks, knowledge and collaborations.

The Advancing BioBusiness Award is an innovative scheme by Merck Sharp & Dohme and Advance, a dynamic, diverse global community of Australian professionals overseas committed to advancing Australia and Australians.

Through the Advancing BioBusiness Award, Dr Wraight said he wants to expand important global connections for Australian science and help facilitate more international business by better understanding what US pharmaceutical companies are looking for in new drug therapies at each stage of what is typically a 10-15 year development process.

Our ultimate customer is the patient. For most Australian pharmaceutical biotechs, however, big pharmaceutical companies are the first customers we need to think about. To provide better drugs for patients we first need to build better research and development programs to attract the best commercialisation partners, Dr Wraight said.

Before they license drugs from biotechs, pharmaceutical companies scrutinise our drug R&D programs with ve
'/>"/>

Contact: Jackie Crossman
jackie@crossmancommunications.com.au
61-293-610-519
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
2. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
3. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
4. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
5. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
7. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
8. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
9. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
10. Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Childrens Hospital at Stanford
11. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... The plastic surgery clinic of ... cosmetic surgery industry with its commitment, teamwork, and dedication — all keys to ... is committed to patient safety, world-class results, and compassionate care. With a determined ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... throughout the Southwest, including Giant, Mustang, Sun Dial and Howdy’s, raised more ... their original 2015 fundraising goal by nearly $100,000, to help support children ...
(Date:7/7/2015)... ... ... reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group A matches featuring ... , The 2015 CONCACAF Gold Cup is now upon us as Group A kicks ... will kick off in Frisco, CA from the Toyota Stadium and will feature two exciting ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... two firms have merged to form Camber Collective. Camber Collective provides strategic ... merger combines SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in ...
(Date:7/7/2015)... California (PRWEB) , ... July 07, 2015 , ... ... connectivity solutions, today announced the CelestixEdge VE and CelestixFederated VA Series virtual appliances. ... and CelestixFederated A Series portfolio of products, which have proven to simplify the ...
Breaking Medicine News(10 mins):Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4
... But sites devoted to complementary or alternative medicine may ... 11 (HealthDay News) -- Just 5 percent of Web ... pages focused on complementary or alternative medicine are 15 ... other false information, a new study says. , Moreover, ...
... DC When the public considers competing arguments about a ... agree with the expert whose values are closest to their ... will hold true for nanotechnology, a key study has found. ... today by the Project on Emerging Nanotechnologies (PEN). The study ...
... ... - $352 Average Patient Charge (APC) ... - $13.9 Million EBITDA From Continuing Operations ... 2008 Guidance, SCOTTSDALE, Ariz., Feb. 11 Rural/Metro,Corporation (Nasdaq: RURL ), a leading provider ...
... National Insurers Bring Programs to the State, While ... According to a New Report from HealthLeaders-InterStudy, ... of managed care market intelligence, reports that pay-for-,performance ... According to the,latest Arizona Health Plan Analysis, the ...
... recent years, increasing attention,has been paid to the ... In some instances, proponents of LBA made,overly-optimistic claims ... predictor in,the underwriting process. Milliman expert Jonathan Shreve, ... effective use of Lifestyle-Based,Analytics as an advance in ...
... SAN JUAN, Puerto Rico, Feb. 11 Triple-S,Management Corporation ... in,Puerto Rico, today announced record consolidated operating income of ... $2.15 for the year ended,December 31, 2007 (including $0.07 ... Company,s strong market position and medical cost,management., ...
Cached Medicine News:Health News:Most Breast Cancer Web Pages Contain Reliable Information 2Health News:Nanotechnology's future depends on who the public trusts 2Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 2Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 3Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 4Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 5Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 6Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 7Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 8Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 9Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 10Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 11Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 12Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 13Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 14Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 15Health News:Pay-For-Performance Not Getting a Red-Carpet Reception in Arizona 2Health News:Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection 2Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 2Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 3Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 4Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 5Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 6Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 7Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 8Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 9Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 10Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 11Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 12Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 13
(Date:7/7/2015)... July 7, 2015  PAREXEL International Corporation (NASDAQ: PRXL ... Fiscal Year 2015 on Wednesday, August 5 th , 2015 ... be available on PAREXEL,s website at www.PAREXEL.com and ... PAREXEL will host a conference call and live webcast at ... to discuss the results.  To access the webcast, visit PAREXEL,s ...
(Date:7/7/2015)... 7, 2015   InspireMD, Inc. (NYSE ... in embolic protection systems ("EPS"), today announced that ... integrated with MicroNet ™ has received the ... Product Innovation Award.  Through active market research efforts, ... consultants recognize the successful introduction of new and ...
(Date:7/7/2015)... ST. PAUL, Minn. , July 7, 2015 /PRNewswire/ ... and manufacturer of devices that use neuroblocking technology to ... the pricing of its previously announced public offering of 32,000,000 ... stock and one Series A warrant to purchase one ... $0.50 per unit. Investors whose purchase of units in ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... 25, 2011 Nano Mask, Inc. (NMI) (Pink Sheets: ... distribution company focused on emergency and critical care as ... has entered into a distribution agreement with a Saudi ... line on an exclusive basis to: The Kingdom of ...
... Food and Drug Administration today approved Firazyr (icatibant) Injection for ... hereditary angioedema (HAE) in people ages 18 years and older. ... ) HAE is caused ... called C1 inhibitor, which is involved in regulating how certain ...
Cached Medicine Technology:Nano Mask Enters Into Four-Year Distribution Agreement With Saudi Medical Products Distributor 2FDA Approves Firazyr To Treat Acute Attacks of Hereditary Angioedema 2
... design and ergonomic handle for easy ... Nitinol markers on the proximal and ... visibility. Corrugated ring design provides flexibility ... ring pattern minimizes stent shortening, provides ...
... Response catheters comprise the world's broadest ... electrophysiology procedures. Their advanced catheter design ... torque response with a soft, atraumatic ... French sizes, Supreme and Response catheters ...
... catheters comprise the world's broadest line ... procedures. Their advanced catheter design and ... response with a soft, atraumatic tip. ... sizes, Supreme and Response catheters provide ...
... Maximum, Maximum Xtra™, and Maximum ... line of standard and specialty ... They are recognized as the ... in interventional cardiology and electrophysiology ...
Medicine Products: